{"CONCEPT_ID":[40171288],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["tocilizumab"],"NUM_PERSONS":[1],"PERCENT_PERSONS":["0.0008"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":59,"P10_VALUE":59,"P25_VALUE":59,"MEDIAN_VALUE":59,"P75_VALUE":59,"P90_VALUE":59,"MAX_VALUE":59}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"50-59","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2020,"Y_PREVALENCE_1000PP":12.987}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":202002,"Y_PREVALENCE_1000PP":0.9747}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":0,"P10_VALUE":0,"P25_VALUE":0,"MEDIAN_VALUE":0,"P75_VALUE":0,"P90_VALUE":0,"MAX_VALUE":0}]}
